Similarly, Majure et al. revealed that compared to COVID-19 patients with normal cardiac troponin I (cTnI), those with mild and severe cTnI elevation had a 1.06-fold and 3.51-fold increased risk of in-hospital death, respectively 28. Here, TNNI3 is linked to COVID-19.